Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 32 studies | 33% ± 15% | |
classical monocyte | 24 studies | 37% ± 13% | |
macrophage | 23 studies | 29% ± 11% | |
pericyte | 21 studies | 34% ± 14% | |
smooth muscle cell | 18 studies | 30% ± 12% | |
conventional dendritic cell | 18 studies | 34% ± 17% | |
connective tissue cell | 14 studies | 38% ± 16% | |
endothelial cell | 12 studies | 30% ± 13% | |
monocyte | 11 studies | 29% ± 11% | |
endothelial cell of lymphatic vessel | 11 studies | 33% ± 11% | |
myofibroblast cell | 11 studies | 35% ± 20% | |
plasmacytoid dendritic cell | 11 studies | 29% ± 8% | |
basal cell | 9 studies | 22% ± 4% | |
dendritic cell | 9 studies | 41% ± 17% | |
non-classical monocyte | 9 studies | 23% ± 7% | |
regulatory T cell | 8 studies | 19% ± 3% | |
epithelial cell | 8 studies | 28% ± 15% | |
myeloid cell | 7 studies | 33% ± 10% | |
endothelial cell of vascular tree | 7 studies | 25% ± 11% | |
mast cell | 7 studies | 24% ± 9% | |
abnormal cell | 6 studies | 23% ± 7% | |
CD4-positive, alpha-beta memory T cell | 5 studies | 18% ± 1% | |
endothelial cell of artery | 5 studies | 19% ± 3% | |
vein endothelial cell | 5 studies | 31% ± 18% | |
hematopoietic precursor cell | 4 studies | 26% ± 6% | |
hematopoietic stem cell | 4 studies | 25% ± 2% | |
mesothelial cell | 4 studies | 33% ± 11% | |
adventitial cell | 4 studies | 25% ± 7% | |
alveolar macrophage | 4 studies | 25% ± 4% | |
intermediate monocyte | 4 studies | 40% ± 15% | |
astrocyte | 4 studies | 22% ± 4% | |
neural crest cell | 3 studies | 19% ± 2% | |
common myeloid progenitor | 3 studies | 32% ± 13% | |
lymphocyte | 3 studies | 20% ± 2% | |
B cell | 3 studies | 17% ± 1% | |
CD4-positive, alpha-beta T cell | 3 studies | 19% ± 0% | |
muscle cell | 3 studies | 32% ± 9% | |
GABAergic neuron | 3 studies | 24% ± 3% | |
glutamatergic neuron | 3 studies | 26% ± 6% | |
goblet cell | 3 studies | 17% ± 1% | |
oligodendrocyte precursor cell | 3 studies | 23% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 16824.27 | 180 / 180 | 100% | 89.28 | 430 / 430 |
prostate | 100% | 14708.21 | 245 / 245 | 100% | 86.46 | 502 / 502 |
thymus | 100% | 12624.65 | 653 / 653 | 100% | 101.54 | 605 / 605 |
skin | 100% | 15830.96 | 1808 / 1809 | 100% | 218.68 | 472 / 472 |
lung | 100% | 13350.49 | 577 / 578 | 100% | 74.59 | 1154 / 1155 |
breast | 100% | 18912.01 | 459 / 459 | 100% | 88.55 | 1115 / 1118 |
uterus | 100% | 21995.02 | 170 / 170 | 100% | 78.79 | 457 / 459 |
intestine | 100% | 16790.82 | 962 / 966 | 100% | 73.06 | 526 / 527 |
bladder | 100% | 21849.48 | 21 / 21 | 99% | 69.72 | 500 / 504 |
esophagus | 100% | 14167.86 | 1441 / 1445 | 99% | 70.77 | 182 / 183 |
kidney | 99% | 9317.21 | 88 / 89 | 100% | 114.81 | 899 / 901 |
adrenal gland | 100% | 14074.56 | 258 / 258 | 98% | 76.87 | 225 / 230 |
stomach | 97% | 10298.77 | 349 / 359 | 100% | 78.09 | 286 / 286 |
brain | 92% | 6674.08 | 2435 / 2642 | 100% | 94.84 | 705 / 705 |
pancreas | 49% | 2013.45 | 162 / 328 | 99% | 77.06 | 177 / 178 |
liver | 37% | 1465.06 | 84 / 226 | 96% | 51.57 | 388 / 406 |
adipose | 100% | 23160.59 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 29731.67 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 56.52 | 29 / 29 |
spleen | 100% | 6849.24 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 55.68 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 27.48 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 99% | 268.59 | 79 / 80 |
heart | 93% | 7071.83 | 801 / 861 | 0% | 0 | 0 / 0 |
muscle | 93% | 5929.35 | 747 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 67% | 3182.26 | 620 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0018400 | Biological process | peptidyl-proline hydroxylation to 3-hydroxy-L-proline |
GO_1901874 | Biological process | negative regulation of post-translational protein modification |
GO_0030199 | Biological process | collagen fibril organization |
GO_0007283 | Biological process | spermatogenesis |
GO_0050821 | Biological process | protein stabilization |
GO_0061077 | Biological process | chaperone-mediated protein folding |
GO_0005615 | Cellular component | extracellular space |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005518 | Molecular function | collagen binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CRTAP |
Protein name | Cartilage-associated protein Cartilage associated protein, isoform CRA_a (cDNA FLJ55123, highly similar to Cartilage-associated protein) Cartilage associated protein |
Synonyms | CASP hCG_1996245 |
Description | FUNCTION: Necessary for efficient 3-hydroxylation of fibrillar collagen prolyl residues. . |
Accessions | ENST00000320954.11 O75718 ENST00000449224.1 C9JP16 B4DPA3 |